Learn More
Invitrogen™ Glypican 1 Polyclonal Antibody

Description
Positive Control: A431, K562, MCF-7, AsPC-1, A431 (24 μg/mL Tunicamycin treatment for 16 hr), A431 (4 mM Benzyl glucosinolate treatment for 32 hr), A431(24 μg/mL Tunicamycin treatment for 16 hr and 4 mM Benzyl glucosinolate treatment for 32 hr) Predicted Reactivity: Mouse (89%), Rat (90%), Rhesus Monkey (98%) Store product as a concentrated solution. Centrifuge briefly prior to opening the vial.
Specifications
Specifications
| Antigen | Glypican 1 |
| Applications | Immunohistochemistry (Paraffin), Western Blot |
| Classification | Polyclonal |
| Concentration | 2.04 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 20% glycerol and 0.025% ProClin 300; pH 7 |
| Gene | GPC1 |
| Gene Accession No. | P35052 |
| Gene Alias | AI462976; glypican; glypican 1; glypican proteoglycan 1; glypican-1; Gpc1; GPI-anchored cell surface heparan sulfate proteoglycan; HSPG M12; HSPGM12; Secreted glypican-1 |
| Gene Symbols | GPC1 |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.